BTEC vs. CNCR

Last updated Jun 5, 2026

BTEC (Principal Healthcare Innovators Index ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - BTEC tracks the NASDAQ U.S. Health Care Innovators Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. BTEC charges 0.42%/yr vs 0.79%/yr for CNCR.

Performance

BTEC vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Principal Healthcare Innovators Index ETF (BTEC) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BTEC

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BTEC vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
BTEC Principal Healthcare Innovators Index ETF	0.00%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

BTEC vs. CNCR - Sectors Allocation Comparison

Sectors	BTEC	CNCR
Healthcare	99.4%	96.6%
Industrials	0.6%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

BTEC vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Principal Healthcare Innovators Index ETF (BTEC) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

BTEC vs. CNCR - Drawdown Comparison

The maximum BTEC drawdown since its inception was 0.00%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BTEC and CNCR.

Drawdown Indicators

	BTEC	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	0.00%	0.00%	0.00%
Current Drawdown Current decline from peak	0.00%	0.00%	0.00%
Average Drawdown Average peak-to-trough decline	0.00%	0.00%	0.00%

Volatility

Volatility by Period

	BTEC	CNCR	Difference
Volatility (1Y) Calculated over the trailing 1-year period	0.00%	0.00%	0.00%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	0.00%	0.00%	0.00%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	0.00%	0.00%	0.00%

BTEC vs. CNCR - Expense Ratio Comparison

BTEC has a 0.42% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

BTEC vs. CNCR - Dividend Comparison

Neither BTEC nor CNCR has paid dividends to shareholders.

Tickers have no history of dividend payments

Frequently Asked Questions

Which ETF is better, BTEC or CNCR?

On fees, BTEC is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BTEC or CNCR?

BTEC is cheaper with a 0.42% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, BTEC or CNCR?

BTEC and CNCR have nearly identical dividend yields, around 0.00%.

What is the main difference between BTEC and CNCR?

BTEC tracks NASDAQ U.S. Health Care Innovators Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Principal and Exchange Traded Concepts. Their fees differ too: 0.42% for BTEC and 0.79% for CNCR.